Glioblastoma: Not Just Another Cancer

Overview

Journal Cancer Discov

Specialty Oncology

Date 2024 Apr 4

PMID 38571415

Authors

Howard A Fine

Affiliations

Soon will be listed here.

Abstract

This commentary urges a paradigm shift in how we approach research and drug development for glioblastoma, reimagining it as an aberrant brain-like organ, distinct from other cancers, to inspire innovative treatment strategies and interdisciplinary collaboration, addressing the minimal progress in extending glioblastoma patient survival despite years of research and investment.

Citing Articles

Distant origin of glioblastoma recurrence: neural stem cells in the subventricular zone serve as a source of tumor reconstruction after primary resection.

Li X, Kim H, Yoo J, Lee Y, Nam C, Park J Mol Cancer. 2025; 24(1):64.

PMID: 40033380 PMC: 11877783. DOI: 10.1186/s12943-025-02273-2.

Bridging the gap between tumor and disease: Innovating cancer and glioma models.

Cirigliano S, Fine H J Exp Med. 2024; 222(1).

PMID: 39626263 PMC: 11614461. DOI: 10.1084/jem.20220808.

Drivers Underlying Metastasis and Relapse in Medulloblastoma and Targeting Strategies.

Holmberg K, Borgenvik A, Zhao M, Giraud G, Swartling F Cancers (Basel). 2024; 16(9).

PMID: 38730706 PMC: 11083189. DOI: 10.3390/cancers16091752.